Sho Okamoto Selected Research

Moyamoya Disease (Moya-Moya Disease)

6/2022	Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onset.
4/2022	Challenging direct bypass surgery for very young children with moyamoya disease: technical notes.
1/2022	Risk Factors for Cerebral Infarction Early After Revascularization in Children Younger than 5 Years with Moyamoya Disease.
8/2021	＜Editors' Choice＞ Indocyanine green emission timing of the recipient artery in revascularization surgery for moyamoya disease.
1/2021	Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya disease.
1/2021	Ipsilateral late stroke after revascularization surgery for patients with Moyamoya disease.
1/2020	Brain Compression by Encephalo-Myo-Synangiosis is a Risk Factor for Transient Neurological Deficits After Surgical Revascularization in Pediatric Patients with Moyamoya Disease.
1/2020	Surgical Designs of Revascularization for Moyamoya Disease: 15 Years of Experience in a Single Center.
5/2018	Postoperative Cerebral Infarction Risk Factors and Postoperative Management of Pediatric Patients with Moyamoya Disease.
4/2018	Intraoperative evaluation of local cerebral hemodynamic change by indocyanine green videoangiography: prediction of incidence and duration of postoperative transient neurological events in patients with moyamoya disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sho Okamoto Research Topics

Disease

14	Moyamoya Disease (Moya-Moya Disease) 06/2022 - 11/2010
4	Aneurysm (Aneurysms) 01/2022 - 06/2016
3	Cerebral Infarction 01/2022 - 06/2016
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2021 - 07/2020
2	Thrombosis (Thrombus) 08/2021 - 01/2021
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2018 - 06/2016
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2022
1	Subdural Hematoma (Subdural Hemorrhage) 01/2021
1	Hematoma 01/2021
1	Stroke (Strokes) 01/2021
1	Ischemia 12/2018
1	Brain Ischemia (Cerebral Ischemia) 12/2018
1	Cognitive Dysfunction 12/2018
1	Disease Progression 05/2018
1	Meningeal Carcinomatosis 05/2018
1	Carcinoma (Carcinomatosis) 05/2018
1	Choriocarcinoma 05/2018
1	Coma (Comas) 05/2018
1	Hemorrhage 05/2018
1	Intracranial Hypertension 06/2016
1	Ruptured Aneurysm 06/2016
1	Wounds and Injuries (Trauma) 11/2015
1	Inflammation (Inflammations) 01/2012
1	Glioma (Gliomas) 07/2003
1	Neoplasms (Cancer) 07/2003

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 04/2018 - 11/2010
2	Tyrosine Kinase InhibitorsIBA 10/2021 - 07/2020
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 08/2021 - 04/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	AnticoagulantsIBA 01/2021
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2018
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2018
1	Cilostazol (Pletal)FDA LinkGeneric 05/2018
1	Analgesics (Analgesic Drugs)IBA 05/2018
1	barbituric acid (barbiturate)IBA 05/2018
1	Fentanyl (Sublimaze)FDA LinkGeneric 05/2018
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 05/2018
1	Hypnotics and Sedatives (Sedatives)IBA 05/2018
1	Dexmedetomidine FDA Link 05/2018
1	Clopidogrel (Plavix)FDA Link 05/2018
1	proenkephalinIBA 01/2018
1	Pharmaceutical PreparationsIBA 06/2016
1	SteroidsIBA 06/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012
1	CytokinesIBA 01/2012
1	ErbB Receptors (EGF Receptor)IBA 07/2003
1	Monoclonal AntibodiesIBA 07/2003
1	epidermal growth factor receptor VIIIIBA 07/2003

Therapy/Procedure

5	Cerebral Revascularization 06/2022 - 01/2020
4	Operative Surgical Procedures 01/2022 - 11/2015
2	Therapeutics 05/2018 - 06/2016
1	Transplantation 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2022
1	Injections 01/2021
1	Drug Therapy (Chemotherapy) 05/2018
1	Ligation 02/2017
1	Decompression 06/2016
1	Craniotomy 11/2015
1	Lasers (Laser) 01/2015
1	Gamma Cameras (Gamma Camera) 07/2003